Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Learn various ways to earn money through gig work. Explore strategies to enhance your income through flexible opportunities.
24,341 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
In 2026, institutional buyers are quietly signaling confidence in diversified energy stocks. A recent stake near $20 ...
Two blue chips face opposite paths as rates stay high and consumer patterns shift. McDonald’s shows earnings growth w...
Pricing conversations in real estate have moved from fixed numbers to dynamic narratives driven by financing, data, a...
Gold and silver slide in tandem as the XAG/XAU ratio tightens, signaling changing bets on safe-haven demand and indus...
BlackRock signals a wallet-first strategy to place traditional stocks and ETFs into regulated digital wallets, aiming...
Insider moves can ripple through biotech stocks. This piece breaks down recent tarsus pharma stock insider activity, ...
Cardano ADA sits in a narrow price band near a critical support level while on chain metrics signal distress among ho...
As AI reshapes business, three stock ideas stand out for potential multi-year gains. This guide breaks down why, how ...
Housing turnover has slipped to multi-decade lows, pushing lenders and agents to rethink pricing. A new framework gui...
Solana Foundation rolled out an AI agent thesis at a major New York summit, arguing a platform shift could redraw Sol...
Barclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...